These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Treatment of type II familial hypercholesteremia through portacaval anastomosis]. Farriaux JP; Ribet M; Bertrand M; Higgins M; Mazzuca M; Luyckx A Arch Fr Pediatr; 1976 Oct; 33(8):745-59. PubMed ID: 185982 [No Abstract] [Full Text] [Related]
44. Bile acid metabolism in hyperlipoproteinaemia. Hellström K; Einarsson K Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796 [No Abstract] [Full Text] [Related]
45. Effect of hypolipidemic drugs on serum lipoproteins. Carlson LA; Olsson AG Prog Biochem Pharmacol; 1979; 15():238-57. PubMed ID: 224397 [No Abstract] [Full Text] [Related]
47. An effective treatment of hypercholesterolaemia using a combination of Secholex and clofibrate. Evans RJ; Howard AN; Hyams DE Angiology; 1973 Jan; 24(1):22-8. PubMed ID: 4694031 [No Abstract] [Full Text] [Related]
48. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)]. Dimroth H Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785 [TBL] [Abstract][Full Text] [Related]
49. Measures to reduce the serum lipid levels in coronary heart disease. Connor WE Med Clin North Am; 1968 Sep; 52(5):1249-60. PubMed ID: 4876837 [No Abstract] [Full Text] [Related]
50. Tracing and treatment of children with essential familial hypercholesterolemia. Andersen GE; Clausen J Z Ernahrungswiss; 1972 Jun; 11(2):120-37. PubMed ID: 4626178 [No Abstract] [Full Text] [Related]
51. [Diagnosis and treatment of primary hyperlipidemias]. Davignon J Arq Bras Cardiol; 1982 Jan; 38(1):59-68. PubMed ID: 6756360 [No Abstract] [Full Text] [Related]
52. Control of biochemical precursors of coronary heart disease. Ostrander LD Geriatrics; 1969 Dec; 24(12):61-6. PubMed ID: 5353631 [No Abstract] [Full Text] [Related]
53. Combined use of clofibrate and cholestyramine or DEAE sephadex in hypercholesterolaemia. Howard AN; Hyams DE Br Med J; 1971 Jul; 3(5765):25-7. PubMed ID: 4933388 [TBL] [Abstract][Full Text] [Related]
54. [Hyperlipidemia and coronary disease]. Krikler DM Coeur Med Interne; 1976; 15(1):3-10. PubMed ID: 793762 [No Abstract] [Full Text] [Related]
55. Diet and drug treatment of hyperlipidemia and atherosclerosis. Kuo PT Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101 [No Abstract] [Full Text] [Related]
56. Continuous flow plasma exchange in the treatment of homozygous familial hypercholesterolemia. Berger GM; Miller JL; Bonnici F; Joffe HS; Dubovsky DW Am J Med; 1978 Aug; 65(2):243-51. PubMed ID: 210664 [TBL] [Abstract][Full Text] [Related]
57. [Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia]. Huth K; Blumenthal J; Schmahl FW Med Klin; 1973 Aug; 68(34):1089-97. PubMed ID: 4790868 [No Abstract] [Full Text] [Related]
58. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. Orö L; Olsson AG; Rössner S; Carlson LA Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639 [No Abstract] [Full Text] [Related]
59. [Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases]. Maíz A; Arteaga A; Villanueva CL; Velasco N; Acosta AM Rev Med Chil; 1990 Sep; 118(9):1009-13. PubMed ID: 2152729 [TBL] [Abstract][Full Text] [Related]